Wegovy is a weight loss injectable drug containing semaglutide. It slows the digestion process, making users feel fuller longer. Wegovy has been shown to help users achieve significant weight loss, making it a popular option for weight management. However, if gastric emptying slows too much, you may experience severe health issues, like gastroparesis (stomach paralysis).
Semaglutide products, including Wegovy, Ozempic, and Rybelsus, are often associated with an increased risk of gastroparesis and other gastrointestinal issues compared to other weight loss medications. Semaglutide also reduces food intake by increasing feelings of fullness, which contributes to its effectiveness in weight loss.
Many consumers often feel as if they weren’t adequately warned about those gastrointestinal issues when they took the medication, causing plaintiffs nationwide to file Wegovy side effects lawsuits against Novo Nordisk (the manufacturer). Drug manufacturers have a legal responsibility to warn consumers about potential risks and serious side effects associated with their products.
If you developed severe gastrointestinal conditions after taking Wegovy, you may be entitled to monetary compensation to cover your medical costs, lost wages, and emotional distress. The potential risks associated with Wegovy use make it important to seek legal advice. Contact a skilled personal injury lawyer today to learn your legal options.
Understanding the Wegovy Lawsuits
The largest Wegovy weight loss drug lawsuit is the multidistrict litigation (MDL) 3094. An MDL streamlines lawsuits against common defendants with similar allegations and facts. This speeds up the legal process by easing the administrative burden for judges.
The Wegovy MDL was created in February 2024. Honorable Judge Karen S. Marston is the presiding judge in this MDL.
As of October 6, 2025, 2,843 claimants have filed lawsuits in the Wegovy MDL in the United States District Court for the Eastern District of Pennsylvania. Of those cases, 2,809 are still active. The MDL has merged lawsuits regarding Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Trulicity, Mounjaro, and Zepbound.
These prescription medications are glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Although the medications are different, they have similar mechanisms, which makes them eligible to be merged into the MDL 3094. Consumers might experience similar health complications from liraglutide, semaglutide, and tirzepatide–the active ingredients of the GLP-1 RAs medications in the MDL 3094.
To file Semaglutide Wegovy lawsuits, you must have:
- Been prescribed Wegovy or another GLP-1 RAs medication by a medical professional and used it as directed.
- Developed a serious health risk that wasn’t listed on the warning or wasn’t adequately warned about.
- Realized that the medication’s maker didn’t advertise possible side effects.
Wegovy lawsuits have named pharmaceutical companies Eli Lilly and Novo Nordisk as defendants. Novo Nordisk manufactures liraglutide and semaglutide products, including Wegovy, while Eli Lilly produces dulaglutide and tirzepatide medications. Plaintiffs are making legal claims that the manufacturers failed to properly warn about the risks and complications associated with these drugs.
Currently, there’s no Wegovy class action lawsuit. However, the Wegovy MDL is similar to a class action suit, but there are differences between the two types of litigation. In these cases, different legal arguments are presented, such as whether the drug was prescribed for off-label use, the dosage, and the specific injuries suffered by plaintiffs.
In a class action lawsuit, one or more plaintiffs file a single case on behalf of a larger group of claimants, collectively referred to as a “class.” That may result in a verdict or settlement award. Plaintiffs included in the class then file a claim to receive their share of the payout amount.
However, in an MDL, separate and individual lawsuits with similar allegations are merged under a single judge, thereby easing the burden on the court system. Cases in the MDL are then tried separately. The lawsuits are then resolved one by one or as a global settlement.
To file a Wegovy lawsuit, individuals must consult with an attorney, gather medical documentation showing they were prescribed Wegovy, and meet legal deadlines to pursue compensation for injuries caused by the drug.
What Is Wegovy?
Wegovy is a prescription medication used for weight loss and diabetes. It’s administered as a weekly dose, but it’s most effective when combined with regular exercise and a healthy diet.
The United States Food and Drug Administration (FDA) approved it in 2021 to help adults who are overweight manage their weight. Semaglutide, the active ingredient in Wegovy, increases feelings of fullness, reducing hunger.
As more patients began taking Wegovy, concerns about its safety, potential health risks, and the responsibilities of its manufacturers have increased.
It’s one of the drugs named in legal actions alleging that weight loss drugs and diabetes medications caused adverse gastrointestinal issues and even vision loss.
Common Side Effects Reported in Ozempic and Wegovy Lawsuits
Wegovy can cause various adverse health complications. Plaintiffs in Wegovy side effects lawsuits claim that the manufacturers were aware of these health risks but failed to provide adequate warnings. Pharmaceutical companies must provide the public with sufficient warnings about potential dangers, including the risk of severe gastrointestinal side effects such as abdominal pain and intestinal blockages, to prevent adverse health effects.
If a drug manufacturer fails to warn the public about the potential toxicity of its medications, it may be held liable under certain circumstances.
Side effects and symptoms linked to Wegovy include:
- Pulmonary embolism and deep vein thrombosis
- Chronic vomiting
- Gastroparesis
- Pancreatic cancer
- Acute kidney injury or failure
- Severe stomach problems
- Abdominal pain
- Intestinal blockages
- Severe stomach issues
- Malnutrition-related issues
- Liver failure
- Pancreatitis
- Gallbladder problems
- Inoperative pulmonary aspiration
- Ileus
- Intestinal or bowel blockage
- Increased risk of thyroid C-cell tumors
- Esophageal injury
- Blindness or vision loss
- Vision problems
- Suicidal thinking or behavior
These serious complications and adverse effects can include vision problems such as non-arteritic ischemic optic neuropathy (NAION), which have led to recent vision loss claims. Plaintiffs allege and plaintiffs claim that the manufacturer failed to warn about these side effects, including the risk of thyroid cancer.
Consumers who have experienced severe side effects after using Wegovy not only developed adverse health issues, but they have also incurred exorbitant medical costs. As a result, people who weren’t well-informed about the possible dangers of taking this medication might have a valid Wegovy lawsuit to recover compensation.
Current Status of Wegovy Multidistrict Litigation
As of September 16, 2025, patients who have become blind while using Wegovy may have new options for legal action. A recent study has linked semaglutide medications to an elevated risk of vision loss. A scientific study published in the JAMA (Journal of the American Medical Association) reports that patients using Wegovy and other semaglutide drugs are twice as likely to suffer from non-arteritic anterior ischemic optic neuropathy or NAION, a rare medical complication causing sudden and painless vision loss because of insufficient blood circulation to the optic nerve. Lawsuits allege that the drug’s manufacturer failed to warn patients about the risk of long term health complications.
As more research shows that semaglutide medications can result in vision loss, the defendants (semaglutide makers) have taken an unusual measure. They have requested that the claims related to vision loss be merged into a group litigation. They want the MDL to be heard in the same federal court as the current group litigation for gastrointestinal injuries, like gastroparesis. That indicates that pharmaceutical companies are aware of the potential adverse side effects associated with Wegovy. Ongoing clinical trials are crucial for identifying these risks and understanding the long-term safety of these medications.
As of September 2025, the existing group lawsuit representing individuals injured by semaglutide medications now has 2,676 active claims. Patients who developed adverse gastrointestinal complications, vision loss, blood clots, and other unfavorable conditions can still join this MDL.
On August 19, 2025, legal experts estimated that the Wegovy lawsuit compensation could exceed $2 billion. Suppose Novo Nordisk, the pharmaceutical company that manufactures Wegovy and other GLP-1 RAs, is found liable. In that case, it may have to pay for medical expenses (both past and future), lost wages, and emotional distress. Also, courts may impose additional penalties if it’s proven that the drug company knowingly hid or downplayed the risks associated with its products.
Novo Nordisk’s responsibility is under scrutiny, as the lawsuits allege the company failed to provide adequate warnings about potential long term health complications. Wegovy lawsuits filed claim that the company failed to inform patients of these risks, and the amount of compensation could grow if more plaintiffs join the current MDL.
Timeline: When Could Wegovy Lawsuits Be Settled?
The Wegovy settlement timeline will vary significantly based on the specifics of each lawsuit. Although some lawsuits may settle quickly, others may take months or even years to be concluded. Factors such as lawsuit complexity, ongoing developments within the lawsuit, and the availability of evidence can impact the timeline.
As of September 30, 2025, the Wegovy litigation is in pretrial and discovery stages. The first bellwether (test) trials aren’t expected until late 2026 or later, based on the complexity and number of plaintiffs. Settlement projections for adverse gastrointestinal cases could range from $500,000 to $1 million. In contrast, NAION cases may result in higher amounts, possibly exceeding $1 million, due to the permanence and severity of the condition. Plaintiffs are seeking financial compensation for their injuries, and many are preparing for legal action against the manufacturer.
The results of the upcoming Daubert hearings will be a monumental point, as the judge’s decision on expert testimonies will determine injuries related to semaglutide before the law. If claimants’ experts are allowed to testify, the MDL may proceed more quickly toward test trials and possible global settlements. If not, many lawsuits might be rejected or significantly reduced.
Potential Financial Compensation for Wegovy Lawsuits
Each Wegovy weight loss drug lawsuit is different, with different claimants and health complications involved. Thus, the compensation amount you may recover in such a lawsuit will vary based on several factors:
- The seriousness of your injuries
- The extent of your emotional and physical suffering
- The amount of medical treatment you received (and the medical bills to go with it)
- Whether you were unable to report to work
If you have a Wegovy lawsuit, you can pursue compensation to cover monetary (economic) and intangible (non-economic) damages in a Wegovy lawsuit. That includes medical costs, medical bills, lost income, emotional distress, loss of enjoyment of life, loss of consortium, and loss of earning capacity.
To build a strong case, it is important to collect medical records that document your injuries and expenses. Working with a legal team can help ensure all necessary documentation is gathered and your claim is thoroughly prepared.
Although there’s no Wegovy lawsuit settlement to compare outcomes to at the moment, we can examine settlement amounts in similar toxic medication lawsuits. Therefore, many complainants’ lawsuits might be worth between $100,000 and $1 million. However, your Wegovy lawsuit compensation (if any) will vary significantly depending on the extent and nature of your damages.
What to Do If You’re Considering to File a Wegovy Lawsuit
If you think you’re eligible to pursue Wegovy lawsuit compensation, you should:
- Stop using Wegovy if you haven’t already: There are other medical treatment options for weight loss and diabetes, and your doctor can help you pick the right choice that suits your specific needs. Continuing to use Wegovy could be detrimental to your health. It could also complicate your claim for monetary compensation.
- Ensure you understand your medical diagnosis and treatment needs: As you progress with plans to file a compensation claim, you must understand your health diagnosis and treatment needs. Here, your priority should be to do everything possible to mitigate the long-term implications of your Wegovy-connected diagnosis. Consult with healthcare providers for proper documentation and support, as their expertise is crucial for both your medical care and legal claim.
- Preserve your medical prescriptions, receipts, Wegovy packaging, and injectors: To file a Wegovy side effects lawsuit, you’ll require proof that you took the drug for diabetes or weight loss management. Therefore, you should preserve any remaining receipts, prescriptions, Wegovy packaging, and injectors. Also, you must gather medical documents that are relevant to your legal claim. Your Wegovy lawsuit attorney will explain what you should do with that evidence to protect your rights.
- Track your medical expenses: Start tracking your medical costs and expenses related to your Wegovy diagnosis. This includes treatment expenses, prescription costs, lost wages, and any emotional distress you experience on a regular basis. All of these expenses will come in handy in calculating the damages you’re entitled to.
- Contact a skilled lawyer: To kickstart the legal process, you’ll need a qualified attorney on your side. Once you contact an attorney, ask them about your legal rights and options to pursue fair compensation. An attorney can help you determine if you’re eligible to file a Wegovy claim. They can also help gather comprehensive evidence to prove your claims. Further, a skilled attorney can calculate the damages you should pursue, and they can fight at every stage of the legal process to ensure you receive what you deserve. Consider seeking help from experienced Wegovy lawyers, who specialize in pharmaceutical litigation and offer dedicated legal support for your case.
At Allconsumer.com, we provide consumers with regular and consistent updates. Our goal is to inform consumers about the latest public concerns. Sign up for our latest newsletter to stay up-to-date with consumer issues.
